A two-part, single- and two-arm randomized, open-label study to evaluate the safety, tolerability and pharmacokinetics and efficacy of KRP203 in subjects undergoing allogeneic hematopoietic cell transplantation for hematological malignancies https://priothera.com/a-two-part-single-and-two-arm-randomized-open-label-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-and-efficacy-of-krp203-in-subjects-undergoing-allogeneic-hematopoietic-cell-trans/
A multicentre, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of the S1P receptor agonist KRP203 in patients with moderately active refractory ulcerative colitis https://priothera.com/a-multicentre-double-blind-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-safety-and-tolerability-of-the-s1p-receptor-agonist-krp203-in-patients-with-moderately-active-refractor/
S1P Receptor-1 agnoist averts the de novo generation of autoreactive T cells in murine acute GvHD https://priothera.com/s1p-receptor-1-agnoist-averts-the-de-novo-generation-of-autoreactive-t-cells-in-murine-acute-gvhd/
Short-term KRP203 and post-transplant cyclophosphamide for graft-versus-host disease prophylaxis https://priothera.com/short-term-krp203-and-post-transplant-cyclophosphamide-for-graft-versus-host-disease-prophylaxis/
GvHD prophylaxis with KRP203, a sphingosine-1-phosphate receptor modulator, is safe and may have the potential to improve survival in patients undergoing allogeneic stem cell transplantation https://priothera.com/gvhd-prophylaxis-with-krp203-a-sphingosine-1-phosphate-receptor-modulator-is-safe-and-may-have-the-potential-to-improve-survival-in-patients-undergoing-allogeneic-stem-cell-transplantation/
The role of S1P receptor-1 agonism in thymus-dependent T cell regeneration and graft-versus-tumor activity following experimental allogeneic hematopoietic cell transplantation https://priothera.com/the-role-of-s1p-receptor-1-agonism-in-thymus-dependent-t-cell-regeneration-and-graft-vs-tumor-activity-following-experimental-allogeneic-hematopoietic-cell-transplantation/
Recent Comments